Literature DB >> 3750868

A qualitative and quantitative analysis of the human fovea during development.

C Yuodelis, A Hendrickson.   

Abstract

The anatomical development of the human fovea has been sampled from 22 weeks gestation to adulthood, using both qualitative and quantitative methods. The foveal depression continues to deepen after birth until 15 months, due to the migration of the cells of the inner retina toward the periphery. Before birth the rod-free zone or foveola is over 1000 microns in diameter, but it becomes progressively narrower after birth because of a centralward migration of cones. It reaches the adult diameter of 650-700 microns by 45 months of age. Postnatally, foveolar cone development is characterized by maturation, elongation, and an increase in packing density. Foveolar cone diameter changes markedly after birth, going from 7.5 microns at 5 days postnatal to 2 microns by 45 months. During this time the foveolar cone develops both its outer segment and basal axon process (fiber of Henle). This combination of elongation and centralward migration results in an increase of foveolar cone density from 18 cones/100 microns at 1 week postnatal to 42 cones/100 microns in the adult. Measures of foveola width and cone diameter reach the adult stage of development at 45 months of age, but the two important visual factors of outer segment length and cone packing density still are only half the adult values at 45 months of age.

Entities:  

Mesh:

Year:  1986        PMID: 3750868     DOI: 10.1016/0042-6989(86)90143-4

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  155 in total

1.  Postnatal maturation of the fovea in Macaca mulatta using optical coherence tomography.

Authors:  Nimesh B Patel; Li-Fang Hung; Ronald S Harwerth
Journal:  Exp Eye Res       Date:  2017-08-02       Impact factor: 3.467

2.  Magnocellular and parvocellular developmental course in infants during the first year of life.

Authors:  Benoit Hammarrenger; Franco Leporé; Sarah Lippé; Mélanie Labrosse; Jean-Paul Guillemot; Marie-Sylvie Roy
Journal:  Doc Ophthalmol       Date:  2003-11       Impact factor: 2.379

3.  Characteristics of the macula in amblyopic eyes by optical coherence tomography.

Authors:  Xin-Mei Wang; Dong-Mei Cui; Ling Zhen; Xiao Yang; Li-Jun Huo; Xing Liu; Jun-Wen Zeng
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

4.  Revealing Henle's fiber layer using spectral domain optical coherence tomography.

Authors:  Brandon J Lujan; Austin Roorda; Robert W Knighton; Joseph Carroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-18       Impact factor: 4.799

5.  The Role of X-Chromosome Inactivation in Retinal Development and Disease.

Authors:  Abigail T Fahim; Stephen P Daiger
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

6.  The assessment of multifocal ERG responses in school-age children with history of prematurity.

Authors:  Marta Michalczuk; Beata Urban; Beata Chrzanowska-Grenda; Monika Oziębło-Kupczyk; Alina Bakunowicz-Łazarczyk; Małgorzata Krętowska
Journal:  Doc Ophthalmol       Date:  2016-01-29       Impact factor: 2.379

Review 7.  Lutein and Zeaxanthin Isomers in Eye Health and Disease.

Authors:  Julie Mares
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

8.  Multifocal ERG in subjects with a history of retinopathy of prematurity.

Authors:  Anne B Fulton; Ronald M Hansen; Anne Moskowitz; Amber M Barnaby
Journal:  Doc Ophthalmol       Date:  2006-02-25       Impact factor: 2.379

9.  Spatial vision of the achromat: spatial frequency and orientation-specific adaptation.

Authors:  M W Greenlee; S Magnussen; K Nordby
Journal:  J Physiol       Date:  1988-01       Impact factor: 5.182

10.  Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema.

Authors:  Farzin Forooghian; Paul F Stetson; Scott A Meyer; Emily Y Chew; Wai T Wong; Catherine Cukras; Catherine B Meyerle; Frederick L Ferris
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.